Critically evaluate a new drug

that targets tau aggregation.

This hypothetical drug prevents the formation of neurofibrillary tangles by

stabilising tau proteins. As a student-researcher:

• Describe

  how this drug might alter disease progression

• Identify

  potential benefits and limitations

• Propose

  an experiment to test its efficacy in a pre-clinical model

• Explain

  how this could address current gaps in AD therapy

[8 marks,

8 minutes]